{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Cancer Care in Transition","description":"In this week\u2019s episode, \u201cCancer Care in Transition: Precision Medicine, Immunotherapy, and Patient Choice,\u201d we look at how cancer treatment is changing at the exact moment when patients are trying to move from crisis mode into something like a new normal. Precision medicine now uses a person\u2019s genes, tumor markers, and even lifestyle to match them with targeted drugs or immunotherapies instead of one\u2011size\u2011fits\u2011all chemo, while immuno\u2011oncology has created a growing group of survivors living with long\u2011term effects and unique follow\u2011up needs. At the same time, shared decision\u2011making has become essential: patients are being asked to weigh complex options with different risks, benefits, costs, and impacts on quality of life\u2014and their preferences, values, and tolerance for uncertainty can dramatically shape which path is \u201cright\u201d for them. We\u2019ll talk about what this transition looks like in real life, how precision tools and immunotherapy are reshaping survivorship, and how patients and caregivers can find their voice when the choices are anything but simple. ","author_name":"PodcastDX","author_url":"https:\/\/www.PodcastDX.Com","html":"